Conference Coverage

Dermatology practice gaps: improving medication management


 

EXPERT ANALYSIS FROM SDEF HAWAII DERMATOLOGY SEMINAR

Protecting against prednisone-induced gastritis

“We underprotect the gut,” Dr. Stratman asserted.

He referred to a recent comprehensive dermatologic review of the prevention and management of glucocorticoid-related side effects, especially the part on peptic ulcer disease (J Am Acad Dermatol. 2017 Jan;76[1]:11-6). This is an issue that heretofore hadn’t been much emphasized in the dermatology literature.

“I read this and thought, ‘Gosh, I’m not really having a conversation with my patients about a review of systems for gut protection as I should. And I certainly haven’t been thinking about prescribing PPIs [proton pump inhibitors] for my patients,’” he recalled.

Dr. Stratman polled his Hawaii Dermatology Seminar audience as to who had ever prescribed a PPI. Most indicated with their electronic clickers that they had never done so.

“This is what a practice gap is,” he commented. “You read the literature and you say, ‘Oh, I guess that makes sense. Maybe I should be doing that more often, or making sure it gets done.’”

“I don’t want to come across as saying, ‘For everybody we put on prednisone we should be giving vitamin D, calcium, and a PPI.’ That’s not the message. The message is, assess your patient – or make sure your patient is being assessed – for risk of peptic ulcer disease. And if you don’t feel comfortable prescribing a PPI, please get the patient connected with their primary care provider, who should,” Dr. Stratman said.

Pages

Recommended Reading

British Society of Rheumatology issues first U.K. lupus guideline
MDedge Internal Medicine
Study highlights disparities in U.S. lupus mortality
MDedge Internal Medicine
Obesity linked to pain, fatigue in SLE
MDedge Internal Medicine
Race may transcend social, geographical parameters in lupus mortality
MDedge Internal Medicine
Blisibimod shows mixed results for lupus in phase 3 trial
MDedge Internal Medicine
Nonadherence to lupus drugs may play a role in frequent hospitalization
MDedge Internal Medicine
Novel oral orphan drug tames pemphigus
MDedge Internal Medicine
Predictors may help to spot risk for hydroxychloroquine nonadherence
MDedge Internal Medicine
VIDEO: Considering systemic disease in dermatology patients
MDedge Internal Medicine
Bloating. Flatulence. Think SIBO
MDedge Internal Medicine